BioSig Technologies, Inc. STEX Accrued Insurance Premium Financing
Accrued Insurance Premium Financing at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:AccruedInsurancePremiumFinancing.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s accrued insurance premium financing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s accrued insurance premium financing?
- BioSig Technologies, Inc. (STEX) reported accrued insurance premium financing of $370K in Q1 2026.
- What does accrued insurance premium financing mean?
- This represents the liability associated with financing insurance premiums, where the company pays for coverage over time rather than in a lump sum. It indicates the company's strategy for managing risk-related cash outflows and its reliance on credit facilities for operational insurance.